Krka, d. d.
KRK
주식 순위
#2281
Krka, d. d. is a leading generic pharmaceutical enterprise primarily involved... Krka, d. d. is a leading generic pharmaceutical enterprise primarily involved in the research, production, promotion, and sale of various pharmaceutical goods. Its market presence spans Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and numerous other international territories. The company's offerings are categorized into prescription medications, over-the-counter products, and veterinary health solutions. Its prescription drug pipeline targets a broad spectrum of medical conditions, including cardiovascular disorders, gastrointestinal issues, central nervous system ailments, pain management, anti-infective treatments, conditions affecting blood and blood-forming organs, urological problems, diabetes, and oncology. The array of non-prescription items includes products for oral and throat care, cough and cold remedies, analgesics, nasal preparations, vitamin and mineral supplements, products designed to enhance cerebral and peripheral circulation, digestive aids, and various general healthcare products. Furthermore, Krka supplies animal health products such as anti-infectives, antiparasitics, and other specialized formulations for both livestock and companion animals. Beyond its pharmaceutical operations, the company also provides health resort and tourist services. Krka, d. d. was established in 1954 and has its corporate headquarters in Novo Mesto, Slovenia.
주가
$288.96
시가총액
$8.75B
변동 (1일)
-7.70%
변동 (1년)
17.36%
국가
SI
거래 Krka, d. d. (KRK)
카테고리
Healthcare
Krka, d. d. (KRK)의 매출
Jun 2026 기준 매출 TTM: $2.51B
Krka, d. d.의 최신 재무 보고서에 따르면 회사의 현재 수익 (TTM)은 $2.51B입니다. 2023년에 회사는 $2.00B의 수익을 올렸으며 이는 2022년의 $1.84B 대비 증가입니다. 수익은 상품이나 서비스를 판매하여 얻은 총 수입을 의미합니다. 수익과는 달리 비용이 차감되지 않습니다.
Krka, d. d.의 수익 기록 (2010 ~ 2026)
매년 말 매출
| 연도 | 매출 | 변화 |
|---|---|---|
| 2026 (TTM) | $2.51B | 26.24% |
| 2024 | $1.99B | -0.50% |
| 2023 | $2.00B | 8.39% |
| 2022 | $1.84B | 3.47% |
| 2021 | $1.78B | -4.75% |
| 2020 | $1.87B | 11.56% |
| 2019 | $1.68B | 9.48% |
| 2018 | $1.53B | 0.72% |
| 2017 | $1.52B | 22.97% |
| 2016 | $1.24B | -2.28% |
| 2015 | $1.26B | -12.29% |
| 2014 | $1.44B | -12.69% |
| 2013 | $1.65B | 9.50% |
| 2012 | $1.51B | 8.31% |
| 2011 | $1.39B | 3.11% |
| 2010 | $1.35B | 0.00% |
유사 기업 또는 경쟁사의 매출
| 회사 | 매출 | 매출 차이 | 국가 |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $6.61B | 163.59% |
IN
|
